NCST, NUCRYST to Sell Its operations and assets to Smith & Nephew for US$21 million. NCST, X-Treme Hot Stock Alert by DrStockPick.com
Dr Stock Pick HOT News & Alerts!
_______________________________________
FREE Daily Stock Alerts From DrStockPick.com
_______________________________________
Wednesday November 11, 2009
DrStockPick.com Stock Report!
**************************************************************
NCST, NUCRYST Pharmaceuticals Corp.
NCST develops, manufactures and commercializes medical products that fight infection and inflammation using SILCRYST(TM), its patented atomically disordered nanocrystalline silver technology.
NCST reported the Execution of a definitive agreement with subsidiaries of Smith & Nephew plc. for the sale to Smith & Nephew of substantially all of NCST’s operations and assets including all rights to its proprietary nanocrystalline silver technology for cash consideration of US$21 million plus the value of working capital and subject to certain adjustments. The closing of the Sale Transaction is subject to customary conditions including the approval of NCST shareholders.
More about NCST at www.nucryst.com
NCST, X-Treme Hot Stock Alert by DrStockPick.com
***********Advertisement***********
******************************
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) . Rule 17B requires disclosure of payment for investor relations.
Tags: nanocrystalline silver technology, NCST, NUCRYST Pharmaceuticals, Smith & Nephew
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
